FDA Drug recall D-0797-2018
Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply
- FDA Drug
- Class II
- terminated
- Published 2018-05-16
On 2018-05-16 the FDA classified a Class II recall of Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply by Kroger Specialty Pharmacy, citing lack of Processing Controls.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0797-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-04-03 |
| Published | 2018-05-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Kroger Specialty Pharmacy |
| Distribution | AR, FL, IL, LA, MS |
Product
Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply
Reason
Lack of Processing Controls.
Identifiers
| code_info | All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0797-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.